Boris Goldstein, PhD

Boris Goldstein

Title: Founder
Company: Brain Scientific
Location: Mission Viejo, California, United States

Boris Goldstein, PhD, Founder at Brain Scientific, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in the field of technology.

Long fascinated by the inner workings of the human brain, Dr. Goldstein has served as the founder and chairman of Brain Scientific since 2015. Having spent his life building technology companies, he focuses his efforts primarily on strategic development and devising new products for brand-related technologies. Particularly well versed in artificial intelligence, neuro-feedback technology, brain-control interfaces and diagnostics for degenerative diseases, such as Alzheimer’s and Parkinson’s, Dr. Goldstein previously established Brain Arrex in 2003 and worked as the director of the Pacific Venture Fund in 1999. He also maintained involvement as the chairperson and chief executive officer of Software House High Technologies from 1989 until 1995.

Among his career accomplishments, Dr. Goldstein is most proud to have invented a “brain tattoo” that can be imprinted on one’s scalp. This invention reads data from the brain and has been leveraged toward the development of artificial intelligence. Additionally, Dr. Goldstein works with various nonprofit organizations, including those seeking to assist children with epilepsy, attention deficit hyperactivity disorder and autism.

Dr. Goldstein’s performance in the field was born of his academic journey, which began at Riga Technical University. During this time, he attained a Bachelor of Arts, a Master of Business Administration and a Doctor of Philosophy – he earned the latter two degrees in 1985 and 1993. Since concluding his edification, Dr. Goldstein has attained numerous awards. In accounting for his success, he credits his forward-facing outlook and eagerness to embrace new technology.

For more information, please visit:

Press Release

Contact Dr. Goldstein:

Leave a Reply